Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:56 pm Purchase | 2022-12-31 | 13G | Histogen Inc. HSTO | ARMISTICE CAPITAL LLC | 224,356 4.990% | 224,356 (New Position) | Filing History |
| 2023-02-08 06:07 am Purchase | 2022-12-31 | 13G | Histogen Inc. HSTO | Mitchell P. Kopin | 240,375 5.300% | 240,375 (New Position) | Filing History |
| 2022-02-14 6:36 pm Purchase | 2021-12-31 | 13G | Histogen Inc. HSTO | ARMISTICE CAPITAL LLC | 247,059 9.890% | 247,059 (New Position) | Filing History |
| 2022-02-11 07:06 am Purchase | 2021-12-31 | 13G | Histogen Inc. HSTO | Mitchell P. Kopin | 264,136 9.990% | 141,408 (+115.22%) | Filing History |
| 2021-06-16 4:06 pm Purchase | 2021-06-07 | 13G | Histogen Inc. HSTO | Mitchell P. Kopin | 122,728 5.600% | 72,728 (+145.46%) | Filing History |
| 2021-01-08 4:28 pm Purchase | 2020-12-30 | 13G | Histogen Inc. HSTO | Mitchell P. Kopin | 50,000 3.600% | 50,000 (New Position) | Filing History |
| 2020-02-05 2:11 pm Sale | 2019-12-31 | 13G | CONATUS PHARMACEUTICALS INC CO CNAT | MPM BioVentures IV QP LP | 0 0.000% | -2,497,027 (Position Closed) | Filing History |